Gene therapy for disorders affecting children, progress and potential

被引:1
|
作者
Anson, Donald S. [1 ]
Fletcher, Janice M.
机构
[1] Univ Adelaide, Dept Paediat, Adelaide, SA 5005, Australia
[2] Children Youth & Womens Hlth Serv, Dept Med Genet, Adelaide, SA, Australia
[3] Flinders Univ S Australia, Dept Biotechnol, Adelaide, SA 5001, Australia
[4] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia
关键词
gene therapy; inherited disorder; paediatrics;
D O I
10.1111/j.1440-1754.2007.01074.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
For over two decades gene therapy has been actively pursued as a treatment modality for the inherited diseases that affect the paediatric population, however, it is still to make a real impact in the clinic. There are many reasons for this including inadequate technology and a lack of understanding of the biological complexities that impact on the efficiency of gene delivery and its outcomes, both positive and negative. However, recent progress is now addressing these issues and indicates that these problems can be overcome, and that gene therapy will play a significant role in the treatment of at least some of these disorders. This review will first give a short overview of relevant gene delivery technologies, what strategies can be used and which diseases are potential targets for gene therapy, and then illustrate several specific diseases for which gene therapy is actively being developed.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 50 条
  • [31] Progress in gene therapy for neurological disorders (vol 9, pg 277, 2013)
    Simonato, Michele
    Bennett, Jean
    Boulis, Nicholas M.
    Castro, Maria G.
    Fink, David J.
    Goins, William F.
    Gray, Steven J.
    Lowenstein, Pedro R.
    Vandenberghe, Luk H.
    Wilson, Thomas J.
    Wolfe, John H.
    Glorioso, Joseph C.
    NATURE REVIEWS NEUROLOGY, 2013, 9 (05) : 277 - 291
  • [32] Gene therapy Progress and Prospects: Gene therapy for the hemophilias
    Christopher E Walsh
    Gene Therapy, 2003, 10 : 999 - 1003
  • [33] Gene therapy Progress and Prospects: Gene therapy for the hemophilias
    Walsh, CE
    GENE THERAPY, 2003, 10 (12) : 999 - 1003
  • [34] Factors Affecting Delayed Referral for Speech Therapy in Iranian Children with Speech and Language Disorders
    Vameghi, R.
    HajiBakhtiari, M.
    Hatamizadeh, N.
    Biglarian, A.
    Rahchamani, M. R.
    ARCHIVES OF REHABILITATION, 2014, 14 : 68 - 77
  • [35] Progress in Clinical Gene Therapy for Cardiac Disorders (vol 27, pg 179, 2023)
    Romeo, Francisco J.
    Mavropoulos, Spyros A.
    Ishikawa, Kiyotake
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (04) : 551 - 552
  • [36] Regulated protein expression for in vivo gene therapy for neurological disorders: Progress, strategies, and issues
    Manfredsson, Fredric P.
    Bloom, David C.
    Mandel, Ronald J.
    NEUROBIOLOGY OF DISEASE, 2012, 48 (02) : 212 - 221
  • [37] Gene therapy for neurological disorders: progress and prospects (vol 17, pg 641, 2018)
    Deverman, Benjamin E.
    Ravina, Bernard M.
    Bankiewicz, Krystof S.
    Paul, Steven M.
    Sah, Dinah W. Y.
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (10) : 768 - 768
  • [38] Synthetic AAV Vectors for the Potential Gene Therapy of Hemophilia in Children
    Shoti, Jakob
    Qing, Keyun
    Srivastava, Arun
    MOLECULAR THERAPY, 2021, 29 (04) : 178 - 178
  • [39] Progress in cancer gene therapy
    Kouraklis, G
    ACTA ONCOLOGICA, 1999, 38 (06) : 675 - 683
  • [40] Progress in Respiratory Gene Therapy
    McLachlan, Gerry
    Alton, Eric W. F. W.
    Boyd, A. Christopher
    Clarke, Nora K. K.
    Davies, Jane C. C.
    Gill, Deborah R. R.
    Griesenbach, Uta
    Hickmott, Jack W. W.
    Hyde, Stephen
    Miah, Kamran M. M.
    Molina, Claudia Juarez
    HUMAN GENE THERAPY, 2022, 33 (17-18) : 893 - 912